Showing results (1421-1430 of 1,436) with videos related to

Sort By:
Pageof 144
Mass Spectrometry Reviews|February 2, 2019
Recommendations for reporting ion mobility Mass Spectrometry measurementsValérie Gabelica, Alexandre A Shvartsburg, Carlos Afonso, et al.
Magnetic Resonance in Medicine|April 22, 2022
Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumorsJinyuan Zhou, Moritz Zaiss, Linda Knutsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2019
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical PracticeLindsey E Roeker, Christopher P Fox, Toby A Eyre, et al.
Plos One|July 9, 2026
Serological evidence of SARS-CoV-2 exposure in marine mammals in the United States between 2020 and 2025Idrissa Nonmon Sanogo, Wendy B Puryear, Alexa F Simulynas, et al.
JAMA Pediatrics|August 5, 2024
Bifidobacterium and Lactobacillus Probiotics and Gut Dysbiosis in Preterm Infants: The PRIMAL Randomized Clinical TrialThea Van Rossum, Annette Haiß, Rebecca L Knoll, et al.
Global Ecology and Biogeography : a Journal of Macroecology|February 18, 2020
Similar factors underlie tree abundance in forests in native and alien rangesMasha T van der Sande, Helge Bruelheide, Wayne Dawson, et al.
Blood Advances|May 19, 2019
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLLAnthony R Mato, Lindsey E Roeker, Toby A Eyre, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Lancet (London, England)|March 7, 2021
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 studyAnthony R Mato, Nirav N Shah, Wojciech Jurczak, et al.
Cancer Medicine|September 24, 2020
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US studyAntonio Cuneo, Anthony R Mato, Gian Matteo Rigolin, et al.
Pageof 144